Vaccine for Influenza Market, Global Outlook and Forecast 2022-2028

April 2022 | 71 pages | ID: V53E8A0AD842EN
Market Monitor Global

Abstracts

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

This report contains market size and forecasts of Vaccine for Influenza in global, including the following market information:

Global Vaccine for Influenza Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Vaccine for Influenza Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Vaccine for Influenza companies in 2021 (%)

The global Vaccine for Influenza market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vaccine for Influenza include Sanofi, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccine for Influenza manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaccine for Influenza Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vaccine for Influenza Market Segment Percentages, by Type, 2021 (%)

• Trivalent Influenza Vaccine
• Quadrivalent Influenza Vaccine

Global Vaccine for Influenza Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vaccine for Influenza Market Segment Percentages, by Application, 2021 (%)

• For Children (6 months to 3 years)
• For Adults and Children over 3 years

Global Vaccine for Influenza Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vaccine for Influenza Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vaccine for Influenza revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Vaccine for Influenza revenues share in global market, 2021 (%)

Key companies Vaccine for Influenza sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Vaccine for Influenza sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• CSL
• GSK
• Mylan
• Hulan Bio
• AstraZeneca
• CCBIO

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vaccine for Influenza Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vaccine for Influenza Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VACCINE FOR INFLUENZA OVERALL MARKET SIZE

2.1 Global Vaccine for Influenza Market Size: 2021 VS 2028
2.2 Global Vaccine for Influenza Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Vaccine for Influenza Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Vaccine for Influenza Players in Global Market
3.2 Top Global Vaccine for Influenza Companies Ranked by Revenue
3.3 Global Vaccine for Influenza Revenue by Companies
3.4 Global Vaccine for Influenza Sales by Companies
3.5 Global Vaccine for Influenza Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Vaccine for Influenza Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Vaccine for Influenza Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccine for Influenza Players in Global Market
  3.8.1 List of Global Tier 1 Vaccine for Influenza Companies
  3.8.2 List of Global Tier 2 and Tier 3 Vaccine for Influenza Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Vaccine for Influenza Market Size Markets, 2021 & 2028
  4.1.2 Trivalent Influenza Vaccine
  4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Vaccine for Influenza Revenue & Forecasts
  4.2.1 By Type - Global Vaccine for Influenza Revenue, 2017-2022
  4.2.2 By Type - Global Vaccine for Influenza Revenue, 2023-2028
  4.2.3 By Type - Global Vaccine for Influenza Revenue Market Share, 2017-2028
4.3 By Type - Global Vaccine for Influenza Sales & Forecasts
  4.3.1 By Type - Global Vaccine for Influenza Sales, 2017-2022
  4.3.2 By Type - Global Vaccine for Influenza Sales, 2023-2028
  4.3.3 By Type - Global Vaccine for Influenza Sales Market Share, 2017-2028
4.4 By Type - Global Vaccine for Influenza Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vaccine for Influenza Market Size, 2021 & 2028
  5.1.2 For Children (6 months to 3 years)
  5.1.3 For Adults and Children over 3 years
5.2 By Application - Global Vaccine for Influenza Revenue & Forecasts
  5.2.1 By Application - Global Vaccine for Influenza Revenue, 2017-2022
  5.2.2 By Application - Global Vaccine for Influenza Revenue, 2023-2028
  5.2.3 By Application - Global Vaccine for Influenza Revenue Market Share, 2017-2028
5.3 By Application - Global Vaccine for Influenza Sales & Forecasts
  5.3.1 By Application - Global Vaccine for Influenza Sales, 2017-2022
  5.3.2 By Application - Global Vaccine for Influenza Sales, 2023-2028
  5.3.3 By Application - Global Vaccine for Influenza Sales Market Share, 2017-2028
5.4 By Application - Global Vaccine for Influenza Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vaccine for Influenza Market Size, 2021 & 2028
6.2 By Region - Global Vaccine for Influenza Revenue & Forecasts
  6.2.1 By Region - Global Vaccine for Influenza Revenue, 2017-2022
  6.2.2 By Region - Global Vaccine for Influenza Revenue, 2023-2028
  6.2.3 By Region - Global Vaccine for Influenza Revenue Market Share, 2017-2028
6.3 By Region - Global Vaccine for Influenza Sales & Forecasts
  6.3.1 By Region - Global Vaccine for Influenza Sales, 2017-2022
  6.3.2 By Region - Global Vaccine for Influenza Sales, 2023-2028
  6.3.3 By Region - Global Vaccine for Influenza Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Vaccine for Influenza Revenue, 2017-2028
  6.4.2 By Country - North America Vaccine for Influenza Sales, 2017-2028
  6.4.3 US Vaccine for Influenza Market Size, 2017-2028
  6.4.4 Canada Vaccine for Influenza Market Size, 2017-2028
  6.4.5 Mexico Vaccine for Influenza Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Vaccine for Influenza Revenue, 2017-2028
  6.5.2 By Country - Europe Vaccine for Influenza Sales, 2017-2028
  6.5.3 Germany Vaccine for Influenza Market Size, 2017-2028
  6.5.4 France Vaccine for Influenza Market Size, 2017-2028
  6.5.5 U.K. Vaccine for Influenza Market Size, 2017-2028
  6.5.6 Italy Vaccine for Influenza Market Size, 2017-2028
  6.5.7 Russia Vaccine for Influenza Market Size, 2017-2028
  6.5.8 Nordic Countries Vaccine for Influenza Market Size, 2017-2028
  6.5.9 Benelux Vaccine for Influenza Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Vaccine for Influenza Revenue, 2017-2028
  6.6.2 By Region - Asia Vaccine for Influenza Sales, 2017-2028
  6.6.3 China Vaccine for Influenza Market Size, 2017-2028
  6.6.4 Japan Vaccine for Influenza Market Size, 2017-2028
  6.6.5 South Korea Vaccine for Influenza Market Size, 2017-2028
  6.6.6 Southeast Asia Vaccine for Influenza Market Size, 2017-2028
  6.6.7 India Vaccine for Influenza Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Vaccine for Influenza Revenue, 2017-2028
  6.7.2 By Country - South America Vaccine for Influenza Sales, 2017-2028
  6.7.3 Brazil Vaccine for Influenza Market Size, 2017-2028
  6.7.4 Argentina Vaccine for Influenza Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Vaccine for Influenza Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Vaccine for Influenza Sales, 2017-2028
  6.8.3 Turkey Vaccine for Influenza Market Size, 2017-2028
  6.8.4 Israel Vaccine for Influenza Market Size, 2017-2028
  6.8.5 Saudi Arabia Vaccine for Influenza Market Size, 2017-2028
  6.8.6 UAE Vaccine for Influenza Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Vaccine for Influenza Major Product Offerings
  7.1.4 Sanofi Vaccine for Influenza Sales and Revenue in Global (2017-2022)
  7.1.5 Sanofi Key News
7.2 CSL
  7.2.1 CSL Corporate Summary
  7.2.2 CSL Business Overview
  7.2.3 CSL Vaccine for Influenza Major Product Offerings
  7.2.4 CSL Vaccine for Influenza Sales and Revenue in Global (2017-2022)
  7.2.5 CSL Key News
7.3 GSK
  7.3.1 GSK Corporate Summary
  7.3.2 GSK Business Overview
  7.3.3 GSK Vaccine for Influenza Major Product Offerings
  7.3.4 GSK Vaccine for Influenza Sales and Revenue in Global (2017-2022)
  7.3.5 GSK Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan Vaccine for Influenza Major Product Offerings
  7.4.4 Mylan Vaccine for Influenza Sales and Revenue in Global (2017-2022)
  7.4.5 Mylan Key News
7.5 Hulan Bio
  7.5.1 Hulan Bio Corporate Summary
  7.5.2 Hulan Bio Business Overview
  7.5.3 Hulan Bio Vaccine for Influenza Major Product Offerings
  7.5.4 Hulan Bio Vaccine for Influenza Sales and Revenue in Global (2017-2022)
  7.5.5 Hulan Bio Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Vaccine for Influenza Major Product Offerings
  7.6.4 AstraZeneca Vaccine for Influenza Sales and Revenue in Global (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 CCBIO
  7.7.1 CCBIO Corporate Summary
  7.7.2 CCBIO Business Overview
  7.7.3 CCBIO Vaccine for Influenza Major Product Offerings
  7.7.4 CCBIO Vaccine for Influenza Sales and Revenue in Global (2017-2022)
  7.7.5 CCBIO Key News

8 GLOBAL VACCINE FOR INFLUENZA PRODUCTION CAPACITY, ANALYSIS

8.1 Global Vaccine for Influenza Production Capacity, 2017-2028
8.2 Vaccine for Influenza Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccine for Influenza Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 VACCINE FOR INFLUENZA SUPPLY CHAIN ANALYSIS

10.1 Vaccine for Influenza Industry Value Chain
10.2 Vaccine for Influenza Upstream Market
10.3 Vaccine for Influenza Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Vaccine for Influenza Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Vaccine for Influenza in Global Market
Table 2. Top Vaccine for Influenza Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Vaccine for Influenza Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Vaccine for Influenza Revenue Share by Companies, 2017-2022
Table 5. Global Vaccine for Influenza Sales by Companies, (K Units), 2017-2022
Table 6. Global Vaccine for Influenza Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Vaccine for Influenza Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Vaccine for Influenza Product Type
Table 9. List of Global Tier 1 Vaccine for Influenza Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine for Influenza Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vaccine for Influenza Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Vaccine for Influenza Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Vaccine for Influenza Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Vaccine for Influenza Sales (K Units), 2017-2022
Table 15. By Type - Global Vaccine for Influenza Sales (K Units), 2023-2028
Table 16. By Application – Global Vaccine for Influenza Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Vaccine for Influenza Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Vaccine for Influenza Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Vaccine for Influenza Sales (K Units), 2017-2022
Table 20. By Application - Global Vaccine for Influenza Sales (K Units), 2023-2028
Table 21. By Region – Global Vaccine for Influenza Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Vaccine for Influenza Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Vaccine for Influenza Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Vaccine for Influenza Sales (K Units), 2017-2022
Table 25. By Region - Global Vaccine for Influenza Sales (K Units), 2023-2028
Table 26. By Country - North America Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Vaccine for Influenza Sales, (K Units), 2017-2022
Table 29. By Country - North America Vaccine for Influenza Sales, (K Units), 2023-2028
Table 30. By Country - Europe Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Vaccine for Influenza Sales, (K Units), 2017-2022
Table 33. By Country - Europe Vaccine for Influenza Sales, (K Units), 2023-2028
Table 34. By Region - Asia Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Vaccine for Influenza Sales, (K Units), 2017-2022
Table 37. By Region - Asia Vaccine for Influenza Sales, (K Units), 2023-2028
Table 38. By Country - South America Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Vaccine for Influenza Sales, (K Units), 2017-2022
Table 41. By Country - South America Vaccine for Influenza Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Vaccine for Influenza Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Vaccine for Influenza Sales, (K Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Vaccine for Influenza Product Offerings
Table 48. Sanofi Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CSL Corporate Summary
Table 50. CSL Vaccine for Influenza Product Offerings
Table 51. CSL Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Vaccine for Influenza Product Offerings
Table 54. GSK Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Mylan Corporate Summary
Table 56. Mylan Vaccine for Influenza Product Offerings
Table 57. Mylan Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Hulan Bio Corporate Summary
Table 59. Hulan Bio Vaccine for Influenza Product Offerings
Table 60. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. AstraZeneca Corporate Summary
Table 62. AstraZeneca Vaccine for Influenza Product Offerings
Table 63. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. CCBIO Corporate Summary
Table 65. CCBIO Vaccine for Influenza Product Offerings
Table 66. CCBIO Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Vaccine for Influenza Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 68. Global Vaccine for Influenza Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Vaccine for Influenza Production by Region, 2017-2022 (K Units)
Table 70. Global Vaccine for Influenza Production by Region, 2023-2028 (K Units)
Table 71. Vaccine for Influenza Market Opportunities & Trends in Global Market
Table 72. Vaccine for Influenza Market Drivers in Global Market
Table 73. Vaccine for Influenza Market Restraints in Global Market
Table 74. Vaccine for Influenza Raw Materials
Table 75. Vaccine for Influenza Raw Materials Suppliers in Global Market
Table 76. Typical Vaccine for Influenza Downstream
Table 77. Vaccine for Influenza Downstream Clients in Global Market
Table 78. Vaccine for Influenza Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Vaccine for Influenza Segment by Type
Figure 2. Vaccine for Influenza Segment by Application
Figure 3. Global Vaccine for Influenza Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vaccine for Influenza Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vaccine for Influenza Revenue, 2017-2028 (US$, Mn)
Figure 7. Vaccine for Influenza Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Vaccine for Influenza Revenue in 2021
Figure 9. By Type - Global Vaccine for Influenza Sales Market Share, 2017-2028
Figure 10. By Type - Global Vaccine for Influenza Revenue Market Share, 2017-2028
Figure 11. By Type - Global Vaccine for Influenza Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Vaccine for Influenza Sales Market Share, 2017-2028
Figure 13. By Application - Global Vaccine for Influenza Revenue Market Share, 2017-2028
Figure 14. By Application - Global Vaccine for Influenza Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Vaccine for Influenza Sales Market Share, 2017-2028
Figure 16. By Region - Global Vaccine for Influenza Revenue Market Share, 2017-2028
Figure 17. By Country - North America Vaccine for Influenza Revenue Market Share, 2017-2028
Figure 18. By Country - North America Vaccine for Influenza Sales Market Share, 2017-2028
Figure 19. US Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Vaccine for Influenza Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Vaccine for Influenza Sales Market Share, 2017-2028
Figure 24. Germany Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 25. France Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Vaccine for Influenza Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Vaccine for Influenza Sales Market Share, 2017-2028
Figure 33. China Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 37. India Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Vaccine for Influenza Revenue Market Share, 2017-2028
Figure 39. By Country - South America Vaccine for Influenza Sales Market Share, 2017-2028
Figure 40. Brazil Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Vaccine for Influenza Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Vaccine for Influenza Sales Market Share, 2017-2028
Figure 44. Turkey Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
Figure 48. Global Vaccine for Influenza Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Vaccine for Influenza by Region, 2021 VS 2028
Figure 50. Vaccine for Influenza Industry Value Chain
Figure 51. Marketing Channels